Estamos realizando la búsqueda. Por favor, espere...
Abstract: Mesenchymal stem cells (MSCs) are the most frequently used stem cells in clinical trials due to their easy isolation from various adult tissues, their ability of homing to injury sites and their potential to differentiate into multiple cell types. However, the realization that the beneficial effect of MSCs relies mainly on their paracrine action, rather than on their engraftment in the recipient tissue and subsequent differentiation, has opened the way to cell-free therapeutic strategies in regenerative medicine. All the soluble factors and vesicles secreted by MSCs are commonly known as secretome. MSCs secretome has a key role in cell-to-cell communication and has been proven to be an active mediator of immune-modulation and regeneration both in vitro and in vivo. Moreover, the use of secretome has key advantages over cell-based therapies, such as a lower immunogenicity and easy production, handling and storage. Importantly, MSCs can be modulated to alter their secretome composition to better suit specific therapeutic goals, thus, opening a large number of possibilities. Altogether these advantages now place MSCs secretome at the center of an important number of investigations in different clinical contexts, enabling rapid scientific progress in this field.
Fuente: World Journal of Stem Cells, 2020 12(12), 1529-1552
Editorial: Baishideng Publishing Group
Fecha de publicación: 01/12/2020
Nº de páginas: 24
Tipo de publicación: Artículo de Revista
Proyecto español: RTI2018-097324
Url de la publicación: https://dx.doi.org/10.4252/wjsc.v12.i12.0000
Consultar en UCrea Leer publicación
ALBERTO GONZALEZ GONZALEZ
DANIEL GARCIA SANCHEZ
JOSE CARLOS RODRIGUEZ REY
FLOR MARIA PEREZ CAMPO